Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-12

Clinical Trial Update: Airway Effects of Tiotropium in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the airway effects of tiotropium in patients with chronic obstructive pulmonary disease has completed and results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spiriva (tiotropium)

Snippet

Sponsor: Imperial College London | Conditions: COPD, LUNG DISEASES, OBSTRUCTIVE | Phase 3 | Status: COMPLETED | Results posted: 2019-11-12